Bio-Thera Solutions, Ltd. (SHA:688177)
16.16
-0.56 (-3.35%)
At close: Nov 16, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 6.69 billion as of November 16, 2026. It is the 9,829th most valuable company in the world and the 2,167th biggest in China. Its market cap has decreased by 39.45% in one year.
Market Cap
6.69B
Enterprise Value
7.35B
Revenue
1.05B
Global Rank
Country Rank
#2,167 China
PE Ratio
n/a
ChartMarket Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 6.69B, a decrease of -73.16%. That is a compound annual growth rate of -17.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 6.69B | -30.16% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 7.65B |
| InventisBio | 7.64B |
| Jiangxi Fushine Pharmaceutical | 7.33B |
| BeBetter Med | 7.30B |
| Daan Gene | 7.28B |
| Novogene | 7.24B |
| Aurisco Pharmaceutical | 7.17B |
| Chengdu Easton Biopharmaceuticals | 7.08B |